Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ELDAPT: Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the oPtimal Treatment Strategy

NCT02284308 is registered in ClinicalTrials.gov with Maastricht Radiation Oncology as lead sponsor.

NCT NCT02284308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02284308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ELDAPT: Elderly With Locally Advanced Lung Cancer: Deciding Through Geriatric Assessment on the oPtimal Treatment Strategy
Lead sponsor
Maastricht Radiation Oncology
Phase
Observational
Overall status
Active, not recruiting
Start date
July 31, 2016
Completion date
December 18, 2029
Enrollment
180 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc